Top Bears Reasons To Sell — Vote below!

Add a New Bears Reason

Company: Schering-Plough (SGP)
Current price:
Headline: (100 character max)
Analysis:
Cancel
80%
agree
5 votes

  Organon was expensive acquisition for Schering-Plough

Organon was a particularly expensive acquisition for Schering-Plough, costing about 3 times its total sales and 15 times its operating profits. If Organon does not pay off, Schering-Plough will have wasted a substantial amount of resources.

(100 character max) Cancel
0%
agree
0 votes

  merck acquisition

hassan is giving awAY SGP

(100 character max) Cancel
25%
agree
4 votes

  Pipeline does not have a strong outlook

The pipeline does not have a strong outlook, with fairly few drugs coming out in the near future. Drug failures are common during development, and Schering-Plough is in a difficult position in having so few potential candidates.

(100 character max) Cancel
25%
agree
4 votes

  Recent challenges to Zetia would be a huge blow

While many of Schering-Plough's patents do not expire for several years, the recent challenges to Zetia would be a huge blow to a company that relies on this drug for most of its revenue.

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki